Finglobenewshour offers Global Life Sciences Conferences: Quarterly Review, an analytical compilation of key trends from the presentations made by the leading Global Life Sciences companies at conferences held during the quarter just completed.
Coverage:
-
➢ Comprehensive focus on 750+ global life sciences companies that have made 1,500+ presentations at 200+ conferences during the most recent quarter
➢ Analyzes the life sciences companies’ presentations available on company websites
➢ Provides monthly share price analysis of global life sciences companies presenting actively versus those presenting less actively and not presenting
➢ Lists the 200+ key healthcare related conferences covered
Key features:
-
➢ Comprehensive analysis of trends of presenters, organizers and contents presented
➢ Compares stock market performance of companies presenting actively versus those presenting less actively and not presenting
➢ Most useful for investors, mutual funds managers, corporate executives, business schools, trade associations and regulatory agencies involved with the global life sciences sector
Table of contents:
Introduction
Section 1. Analysis of 750+ global life sciences companies presented at investor conferences during the last quarter:
1.1: By region (Africa/Middle East, Americas, Asia and Europe)
1.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
1.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
1.4: By type of conferences (healthcare investor conferences, finance conferences, medical/scientific conferences and general healthcare conferences)
Section 2. Contents provided by 750+ global life sciences companies in their presentations
2.1: Financial summary related topics
2.2: Product related topics
2.3: Research related topics
2.4: Expansion related topics (diversification, mergers and acquisitions etc)
2.5: Industry and regulatory approval related topics
Section 3. Stock market performance vs. conference participation
Monthly stock price return analysis for companies actively presented during the last quarter versus those presented less actively and not presented during the quarter just completed: By
3.1: By region (Africa/Middle East, Americas, Asia and Europe)
3.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
3.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
Appendices
Appendix A: List of 200 conferences covered
A.1: By name
A.2: By type of conference
A.3: By date of conference
A.4: By country and city where held
Appendix B: List of 750 life sciences companies covered
B.1: By region, country, and company
B.2: By sub-industry, country, and company
B.3: By market capitalization, country, and company
B.4: By type of conference, conference, presenting companies- listed by country